Status | Study |
Completed |
Study Name: Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. Condition: Carcinoma, Pancreatic Ductal Date: 2023-01-31 Interventions: Procedure: Selective extended dissection of pancreaticoduodenectomyAn optimized procedure of pancreaticoduodenectomy which is based on the extra |
Recruiting |
Study Name: A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma Condition: Carcinoma, Pancreatic Ductal Date: 2016-12-13 Interventions: Drug: Napabucasin Napabucasin |
Recruiting |
Study Name: Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma Condition: Carcinoma, Pancreatic Ductal Date: 2016-10-06 Interventions: Procedure: Extended lymphadenectomy |
Completed |
Study Name: Continuous Monitoring on the General Ward Condition: Carcinoma, Pancreatic Ductal Colorectal Neoplasms Date: 2016-07-25 Interventions: Device: HealthPatch The Health |
Recruiting |
Study Name: Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas Condition: Carcinoma, Pancreatic Ductal Date: 2016-02-10 Interventions: Other: samples of blood, saliva and urine Spot samples of Blood, urine and saliva |
Recruiting |
Study Name: Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection Condition: Carcinoma, Pancreatic Ductal Date: 2016-01-19 Interventions: Genetic: Molecular Profiling Whole Genome Sequencing |
Recruiting |
Study Name: Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer Condition: Carcinoma, Pancreatic Ductal Date: 2015-12-04 Interventions: Drug: Parvovirus H-1 (H-1PV) Parvovirus H-1 administered a |
Active, not recruiting |
Study Name: Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma Condition: Metastatic Pancreatic Ductal Adenocarcinoma Date: 2015-10-20 Interventions: Drug: MEDI4736 in combination with nab-paclitaxel and gemcitabine |
Active, not recruiting |
Study Name: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma Condition: Metastatic Pancreatic Ductal Adenocarcinoma Date: 2015-08-27 Interventions: Drug: MEDI4736 monotherapy MED |
Recruiting |
Study Name: Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer Condition: Carcinoma, Pancreatic Ductal Date: 2015-08-18 Interventions: Other: iAPA-DC/CTL adoptive cellular immunotherapy |